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Gastric parietal cells migrate from the 
luminal to the basal region of the gland and 
they gradually lose acid secretory activity. So 
far, distribution and function of K+-Cl- 
cotransporters (KCCs) in gastric parietal cells 
have not been reported. We found that KCC3a 
but not KCC3b mRNA was highly expressed 
and KCC3a protein was predominantly 
expressed in the basolateral membrane of rat 
gastric parietal cells located in the luminal 
region of the glands. KCC3a and 
Na+,K+-ATPase α1-subunit (α1NaK) were 
co-immunoprecipitated and both of them were 
highly localized in a lipid raft fraction.     
The ouabain-sensitive K+-dependent  
ATP-hydrolyzing activity (Na+,K+-ATPase 
activity) was significantly inhibited by a KCC 
inhibitor (DIOA). The stable exogenous 
expression of KCC3a in LLC-PK1 cells 
resulted in association of KCC3a with 
endogenous α1NaK and it recruited α1NaK in 
lipid rafts, accompanying increases of 
Na+,K+-ATPase activity and ouabain-sensitive 
Na+ transport activity which were suppressed 
by DIOA, while the total expression level of 
α1NaK in the cells was not significantly altered. 
On the other hand, the expression of KCC4 
induced no association with α1NaK. In 
conclusion, KCC3a forms a functional complex 
with α1NaK in the basolateral membrane of 
luminal parietal cells and it up-regulates 
α1NaK in lipid rafts, while KCC3a is absent in 
basal parietal cells. 
 
Cation-chloride cotransporter gene family 
(SLC12)1 include Na+-Cl- cotransporters, 
Na+-K+-2Cl- cotransporters (NKCCs) and K+-Cl- 
cotransporters (KCCs). KCCs mediate an 
electroneutrally-coupled transport of K+ and Cl- 
and contribute to transepithelial transport and cell 
volume regulation (1, 2). KCCs are encoded by at 
least four homologues genes (KCC1-KCC4), and 
KCC3 has three isoforms (KCC3a-KCC3c) 
generated by the difference of first coding exons 
(3-5). KCC1 is widely expressed, whereas KCC2 
and KCC3b are restricted in neuron and kidney, 
respectively. KCC3a and KCC4 are mainly 
expressed in epithelial cells (3-5). 
Among the SLC12 family, Na+-K+-2Cl- 
cotransporter-1 (NKCC1) is present in the 
basolateral membrane of gastric parietal cells (6). 
NKCC1 was reported to be not involved in the 
gastric acid (HCl) secretion, but involved in 
non-acidic electrogenic ion secretions in mouse 
parietal cells (7, 8). So far, the distribution and 
function of KCCs have not been reported in the 
gastric parietal cells. 
Lipid rafts are glycosphingolipid- and 
cholesterol-enriched microdomains and are 
thought to be the functional domains involved in 
membrane trafficking and signal transduction 
(9-11). Recently, it has been reported that some 
transporters and channels, such as Na+,K+-ATPase 
(12, 13), Na+/H+ exchanger-3 (NHE3) (14, 15), 
and epithelial Na+ channel (ENaC) (16) are 
localized in lipid rafts of several tissues. However, 
little is known about lipid rafts of gastric parietal 
cells. 
In the present study, we studied distribution of 
KCC3a and association of KCC3a with 
Na+,K+-ATPase α1-subunit (α1NaK) in the gastric 
mucosa. In addition, we studied recruitment of 
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α1NaK by KCC3a in lipid rafts using the cells 




Materials-  Anti-rat KCC3 rabbit polyclonal 
antibody was generated with KLH-coupled 
peptides against 19 amino acids corresponding to 
the N-terminus sequence of KCC3 
(KKARNAYLNNSNYEEGDEY). Both KCC3a 
and b contain this N-terminus sequence. This 
antigen peptide has no homology with the 
sequences of KCC1, 2 and 4. Anti-Na+,K+-ATPase 
α1-subunit (α1NaK) mouse monoclonal antibody 
was obtained from Upstate biotech (Lake Placid, 
NY, USA). Anti-H+,K+-ATPase α-subunit mouse 
monoclonal antibody (1H9) was from Medical & 
Biological Laboratories Co. (Nagoya, Japan). 
Anti-flotillin-2 mouse monoclonal antibody (B-6) 
and anti-human aquaporin-4 (AQP4) goat 
polyclonal antibody (H-19) were from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). 
Lipofectamine 2000, anti-Xpress mouse 
monoclonal antibody, Alexa Fluor 
488/546-conjugated anti-mouse IgG antibody, 
Alexa Fluor 488/546-conjugated anti-rabbit IgG 
antibody and Alexa Fluor 546-conjugated 
anti-goat IgG antibody were from Invitrogen 
(Carlsbad, CA, USA). Ouabain, SCH 28080, 
methyl-β-cyclodextrin (MβCD) and 
R-(+)-[(2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3- 
dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid 
(DIOA) were from Sigma-Aldrich (St. Louis, MO, 
USA). Protein A-agarose beads was from Pierce 
(Rockford, IL, USA). Hygromycin B and 
blasticidin S were obtained from Wako Pure 
Chemical Industries (Osaka, Japan) and Kaken 
Pharmaceutical Co. (Tokyo, Japan), respectively. 
22NaCl was obtained from PerkinElmer Life 
Sciences (Boston, MA, USA). 
Isolation of tissues and cells- The cell suspension 
rich in parietal cells and the gastric gland 
suspension were prepared from rabbit stomach as 
previously described (17). Human gastric mucosa 
was obtained from surgical resection of Japanese 
patients at Toyama University Hospital in 
accordance with the recommendations of the 
Declaration of Helsinki and with the ethics 
committee approval. All patients gave informed 
consent. 
Northern blotting- Poly A+ RNA of the cells was 
prepared by using PolyATtract mRNA isolation 
system II (Promega, Madison, WI, USA). The 
amplified products were sequenced and used for 
the preparation of the 32P-labeled cDNA probes. 
The rabbit KCC3 probe was 712 bp long and 
corresponded to nucleotides 806-1507 of the 
KCC3a cDNA. The poly A+ RNA (2.5 µg) was 
separated on a 1% agarose/formaldehyde gel and 
transferred onto a nylon membrane (Zeta-probe 
GT, Bio-Rad). The membrane was hybridized 
with the 32P-labelled cDNA fragment for 
overnight at 65°C in 250 mM NaH2PO4-Na2HPO4 
(pH7.2)-7% SDS, washed in 40 mM 
NaH2PO4-Na2HPO4 (pH7.2)-1% SDS at 65°C, and 
exposed to the Imaging Plate (Fuji Film) for 20 h. 
Plasmid construction-  Full-length cDNAs 
encoding rat KCC3a and rat KCC4 were inserted 
into pcDNA4/His vector (Invitrogen) by using 
KpnI/NotI and EcoRI/XbaI restriction sites, 
respectively (KCC3a-pcDNA4/His vector and 
KCC4-pcDNA4/His vector) and also inserted into 
pcDNA5/TO vector (Invitrogen) by using 
AflII/NotI and AflII/XbaI restriction sites, 
respectively (KCC3a-pcDNA5/TO vector and 
KCC4-pcDNA5/TO vector). 
Expression of KCC3a and KCC4 in cultured cells- 
To establish the tetracycline-regulated expression 
system of KCC3a or KCC4 in LLC-PK1 cells, the 
cells were cotransfected with pcDNA6/TR vector 
(Invitrogen), KCC3a-pcDNA5/TO or 
KCC4-pcDNA5/TO vector by using 
Lipofectamine 2000 and cultured for 24 h in 
DMEM supplemented with 10% fetal bovine 
serum (FBS). The transfected cells were selected 
in the presence of 800 units/ml hygromycin B and 
5 µg/ml blasticidin S. For transient expression of 
KCC3a in HEK293 cells stably expressing gastric 
H+,K+-ATPase (18), the cells were transfected 
with the KCC3a-pcDNA4/His vector by using 
Lipofectamine 2000 and cultured for 24 h in 
DMEM supplemented with 10% FBS. 
Western blotting- Preparation of membrane 
fractions and Western blotting were carried out as 
described previously (19). Signals were visualized 
with the ECL Plus system (GE Healthcare, 
Buckinghamshire, UK). To quantify the 
chemiluminescence signals on the membranes, a 
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FujiFilm’s LAS-1000 system and the MultiGauge 
software were used. Anti-KCC3, anti-Xpress and 
anti-H+,K+-ATPase (1H9) antibodies were used at 
1:1,000 dilution and anti-α1NaK antibody was 
used at 1:10,000 dilution. Anti-flotillin-2 antibody 
was used at 1:2,000 dilution. For negative control, 
one volume of each primary antibody was 
pre-incubated with five volumes of the 
corresponding blocking peptide. Horse-radish 
peroxidase-conjugated anti-mouse, anti-rabbit or 
anti-goat IgG was used as a secondary antibody 
(1:2,500 dilution). 
Immunohistochemistry- The gastric mucosa 
isolated from rat stomach was embedded in the 
O.C.T. compound (Sakura Finetechnical Co., 
Tokyo, Japan) and was cut at 8 µm. The sections 
were fixed in ice-cold methanol for 7 min at room 
temperature and were pre-treated with the 3% 
bovine serum albumin (BSA) for 1 h at room 
temperature to block non-specific binding of 
antibody. Then, they were incubated with 
anti-KCC3, anti-H+,K+-ATPase (1H9), 
anti-α1NaK or anti-AQP4 antibody (1:100 
dilution) for overnight at 4°C. Alexa Fluor 
488-conjugated and Alexa Fluor 546-conjugated 
anti-IgG antibodies (1:100 dilution) were used as 
secondary antibodies. Immunofluorescence 
images were visualized by using a Zeiss LSM 510 
laser scanning confocal microscope.  
Immunocytochemistry- LLC-PK1 cells were fixed 
with ice-cold methanol for 7 min and 
permeabilized with phosphate buffered saline 
(PBS) containing 0.3% Triton X-100 and 0.1% 
BSA for 15 min at room temperature. 
Non-specific binding was blocked by 3% BSA. 
The permeabilized cells were incubated with the 
anti-Xpress or anti-α1NaK antibody (1:100 
dilution) for overnight at 4°C, and then with the 
Alexa Fluor 488-conjugated or Alexa Fluor 
546-conjugated anti-IgG antibody (1:100 dilution) 
for 1 h at room temperature. Immunofluorescence 
images were visualized by using a Zeiss LSM 510 
laser scanning confocal microscope. 
Isolation of lipid rafts- Membrane proteins were 
lysed with the ice-cold MBS buffer (150 mM 
NaCl, 25 mM MES-NaOH, pH 6.5) containing  
1% 3-[(3-cholamidopropyl)dimethyl-ammonio] 
propanesulfonic acid (CHAPS), 10 µg/ml 
aprotinin, 10 µg/ml phenylmethylsulfonyl 
fluoride, 1 µg/ml leupeptin and 1 µg/ml pepstatin 
A for 15 min. The solution was mixed with equal 
volume of 66% sucrose in MBS buffer, and the 
mixture was placed at the bottom of an 
ultracentrifuge tube and a discontinuous gradient 
was formed by overlaying with the 30% sucrose 
and the 5% sucrose solutions. The sample was 
centrifuged at 261,000 x g in SW41Ti rotor 
(Beckman) for 18 h at 4°C. Ten fractions of 1 ml 
each were collected from the top of the gradient 
and proteins were precipitated by acetone before 
SDS-polyacrylamide gel electrophoresis and 
Western blotting. For depletion of cholesterol, the 
cells were treated with 10 mM MβCD for 30 min 
at 37°C before harvesting the cells.   
Immunoprecipitation- Membrane fractions of rat 
gastric mucosa (500 µg of protein) and 
KCC3a-expressing LLC-PK1 cells (2.5 mg of 
protein) were solubilized in the 500 µl of lysis 
buffer (PBS containing 0.5% Triton X-100, 0.1% 
BSA and 1 mM EDTA) for 30 min on ice, and 
centrifuged at 90,000 x g for 30 min at 4°C. The 
lysate was precleared with protein A-agarose 
beads and the supernatant was incubated with 
anti-KCC3 antibody or control rabbit IgG for 24 h 
at 4°C with end-over-end rotation. The 
antibody-antigen complexes were incubated with 
protein A-agarose beads for 4 h at 4°C with 
end-over-end rotation. Then, the beads were 
washed three times with the lysis buffer and 
suspended in SDS sample buffer. The samples 
were used for Western blotting. 
Measurement of Na+,K+-ATPase activity- 
Na+,K+-ATPase activity of LLC-PK1 (30 µg of 
protein) and membrane fractions of the rabbit 
gastric glands (30 µg of protein) and rabbit kidney 
(3 µg of protein) was measured in a 1 ml of 
solution containing 120 mM NaCl, 15 mM KCl, 3 
mM MgSO4, 1 or 3 mM ATP, 50 µM SCH 28080 
and 40 mM Tris-HCl (pH 7.4), in the presence or 
absence of 100 µM ouabain. After incubation for 
10 or 30 min at 37°C, the reaction was terminated 
by addition of the ice-cold stop solution 
containing 12% perchloric acid and 3.6% 
ammonium molybdate, and inorganic phosphate 
released was measured (20). The Na+,K+-ATPase 
activity was calculated as the difference between 
the activities in the presence and absence of 
ouabain. 
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Measurement of phosphorylation level of 
Na+,K+-ATPase- Ten µg of membrane proteins 
were phosphorylated in a solution comprising 2 
µM [γ-32P]-ATP (4 x 106 cpm), 20 mM NaCl, 0.43 
mM MgCl2, and 25 mM imidazole-HCl (pH 6.0) 
for 20 s at 0°C.  The reaction was quenched by 
the solution containing 10% trichloroacetic acid, 
10 mM inorganic phosphate and 1 mM ATP. 
Then, the samples were centrifuged at 13,000 x g 
for 3 min at 4°C, and the pellet was washed with 
ice-cold 10% TCA,  solubilized in a sample 
buffer comprising 2% SDS, 2.5% dithiothreitol, 
10% glycerol and 50 mM Tris-HCl (pH 6.8) and 
subjected to the 5% SDS-polyacrylamide gel 
electrophoresis under acidic conditions at pH 6.0 
(21, 22). The radioactivity associated with the 
Na+,K+-ATPase α-subunit separated on the gel 
was visualized and quantified by a digital 
autoradiography of the dried gel using 
Bio-Imaging Analyzer BAS2000 (Fuji Film).  
Measurement of H+,K+-ATPase activity- 
H+,K+-ATPase activity of HEK293 cells (30 µg of 
protein) was measured in a 1 ml of solution 
containing 15 mM KCl, 3 mM MgSO4, 1 mM 
ATP, 5 mM NaN3, 2 mM ouabain and 40 mM 
Tris-HCl (pH 6.8) in the presence or absence of 50 
µM SCH 28080, a specific inhibitor of 
H+,K+-ATPase. After incubation for 30 min at 
37°C, the reaction was terminated by addition of 
the ice-cold stop solution containing 12% 
perchloric acid and 3.6% ammonium molybdate, 
and inorganic phosphate released was measured 
(20). 
Measurement of 22Na+ transport activity- Na+ 
transport activity of LLC-PK1 cells was estimated  
by measuring intracellular 22Na+ content (23, 24). 
In each well of 12-well culture plates, 1 x 105 cells 
equipped with the tetracycline-regulated 
expression system of KCC3a were seeded and 
cultured in DMEM supplemented with 10% FBS 
for 2 days, followed by treatment with or without 
2 µg/ml tetracycline for 24 h. The treated cells 
were incubated at 37°C in the culture medium 
containing trace amounts of 22Na+ (0.5 µCi/ml) for 
120 min to fully equilibrate exchangeable 
intracellular Na+ with 22Na+. The 22Na+-loaded 
cells were incubated at 37°C for additional 30 min 
in the presence and absence of 10 µM ouabain. 
Cells were then washed three times with ice-cold 
solution of 100 mM MgCl2 and dissolved in 1 ml 
of the solution containing 1% SDS. 22Na+ contents 
in the samples were measured in a γ-counter 
(Aloka AccuFLEXγ7001, Aloka Co., Tokyo, 
Japan). The Na+ transport activity of 
Na+,K+-ATPase was estimated as the difference 
between the intracellular 22Na+ contents in the 
presence and absence of ouabain.               
Statistics- Results are shown as means ± S.E. 
Differences between groups were analyzed by 
one-way ANOVA, and correction for multiple 
comparisons was made by using Dunnett’s 
multiple comparison test. Comparison between the 
two groups was made by using Student’s t test. 
Statistically significant differences were assumed 




Expression of KCC3a in gastric parietal cells. 
Northern blotting with the KCC3 cDNA probe 
gave a strong band of ~8 kb and faint band of ~7 
kb in the preparation of rabbit gastric parietal cells 
(Fig. 1A). The transcript sizes of KCC3a and 
KCC3b were reported to be around 8 and 7 kb, 
respectively (25). Western blotting with the 
anti-KCC3 antibody showed a single band of ~180 
kDa in the samples from rats, rabbits and humans 
(Fig. 1B, upper panel). The specificity of the 
antibody for the 180 kDa-band was confirmed by 
using the corresponding blocking peptide (Fig. 
1B, lower panel). KCC3b protein was reported to 
be expressed abundantly in kidney (5), thus we 
compared the band size of KCC3 expressed in the 
gastric mucosa with that expressed in the kidney 
of rats (Fig. 1C). The band size of the gastric 
mucosa (180 kDa) was apparently greater than 
that in the kidney (150 kDa). These results suggest 
that KCC3a mRNA and protein are predominantly 
expressed in gastric mucosa. 
In the immunohistochemistry of isolated rat 
gastric mucosa, the distribution pattern of KCC3a 
(Fig. 2, A, C, D and F) was apparently different 
from that of H+,K+-ATPase (Fig. 2, B, C, E and 
F). KCC3a was co-localized with Na+,K+-ATPase 
α1-subunit (α1NaK) (Fig. 2, J-L), suggesting that 
it is present in the basolateral membrane of gastric 
parietal cells. The specificity of anti-KCC3 
antibody for positive staining was confirmed by 
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using the blocking peptide (Fig. 2, G-I). 
Aquaporin-4 (AQP4) was abundantly expressed in 
the basal parietal cells (Fig. 2, M and N) as 
previously reported (26). 
Previously, younger parietal cells in the 
luminal region of the glands have been reported to 
secrete acid more actively than do older parietal 
cells in the basal region (27-29). Interestingly, the 
present double immunostaining of KCC3a and 
AQP4 in rat gastric mucosa has shown clearly that 
KCC3a is predominantly expressed in the luminal 
parietal cells (Fig. 2M).   
Association of KCC3a with α1NaK in the 
gastric mucosa. To study whether KCC3a is 
associated with α1NaK in rat gastric mucosa, 
immunoprecipitation was performed by using an 
anti-KCC3 antibody. The subsequent Western 
blotting of the immune pellets with an anti-α1NaK 
antibody gave a clear band for α1NaK (100 kDa), 
while that with an anti-H+,K+-ATPase antibody 
gave no band for H+,K+-ATPase (95 kDa) (Fig. 
3A). These results suggest that KCC3a is 
associated with α1NaK in gastric parietal cells. 
Distribution of KCC3a and α1NaK in lipid 
rafts in rat gastric mucosa. Lipid rafts are known 
to be insoluble for treatment with non-ionic 
detergents such as Triton X-100 and CHAPS at 
low temperature and form detergent resistance 
membrane (DRM) fractions with low density (9). 
In the present study, lipid rafts were isolated from 
rat gastric mucosa by using CHAPS and sucrose 
gradient. Flotillin-2 was used as a marker for lipid 
rafts (30, 31). As shown in Fig. 3B, most of 
KCC3a and α1NaK were distributed in the DRM 
fractions, in which flotillin-2 was also expressed 
(Fig. 3B).  
Tetracycline-regulated stable expression of 
KCC3a in LLC-PK1 cells. Next, we constructed 
the tetracycline-regulated stable expression system 
of KCC3a in LLC-PK1 cells, a hog kidney 
proximal tubular cell line (Fig. 4). No significant 
expression of endogenous KCC3a was observed in 
control LLC-PK1 cells (data not shown). In this 
heterologous expression system, exogenous 
expression of KCC3a protein was assessed by 
using an anti-Xpress antibody. Expression of 
KCC3a (180 kDa) was observed in the cells 
treated with tetracycline (tet-on cells), while no 
significant expression of KCC3a was observed in 
the cells treated without tetracycline (tet-off cells) 
(Fig. 4A). Both KCC3a and α1NaK were found to 
be present in the basolateral membrane of the 
tet-on cells (Fig. 4, F and G). Expression pattern 
of α1NaK in the tet-on cells was similar to that in 
the tet-off cells (Fig. 4, D and E). 
Distribution of KCC3a and α1NaK in lipid 
rafts in the heterologous expression system. Lipid 
rafts were isolated from the tet-on and tet-off cells 
(Fig. 5). In the tet-off cells, 33.0 ± 4.1% of total 
α1NaK was in DRM fractions in which flotillin-2 
was localized, and 67.0 ± 4.1% of total α1NaK 
was in non-DRM fractions (Fig. 5, A and C). In 
the tet-on cells, KCC3a was predominantly 
distributed in the DRM fractions, and an increased 
amount of α1NaK (76.9 ± 2.1%) was localized in 
the DRM fractions (Fig. 5, B and C). These 
findings suggest that the presence of KCC3a 
induces a significant recruitment of α1NaK from 
non-DRM fractions into the DRM fractions. 
Furthermore, depletion of cholesterol with MβCD 
(10 mM) shifted the distributions of both KCC3a 
and α1NaK from the DRM fractions to the 
non-DRM fractions (Fig. 5, B and D). 
Up-regulation of Na+,K+-ATPase activity by 
KCC3a. To study whether KCC3a is associated 
with α1NaK in the tet-on cells as well as the case 
in the rat gastric mucosa (Fig. 3A), 
immunoprecipitation was performed by using an 
anti-KCC3 antibody. The subsequent Western 
blotting of the immune pellets with an anti-α1NaK 
antibody gave a single band for α1NaK (100 kDa) 
(Fig. 6A). The anti-α1NaK antibody gave no band 
in the immune pellets obtained with the rabbit IgG 
used as a negative control (Fig. 6A).  
Next, we examined the functional relationship 
between KCC3a and α1NaK. Although the total 
expression level of α1NaK in the tet-on cells was 
not significantly different from that in the tet-off 
cells (Fig. 6B), the ouabain-sensitive K+-ATPase 
activity (Na+,K+-ATPase activity) in the tet-on 
cells was significantly greater than that in the 
tet-off cells (Fig. 6C). 
Effects of KCC3a on H+,K+-ATPase activity. 
Here, we used HEK293 cells that stably express 
exogenous H+,K+-ATPase α- and β-subunits (18). 
Additional exogenous expression of KCC3a 
changed neither expression level of H+,K+-ATPase 
nor the SCH 28080-sensitive K+-ATPase activity 
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(H+,K+-ATPase activity) in the cells 
(Supplemental Fig. 1). 
Elevation of phosphorylation level of 
Na+,K+-ATPase by KCC3a. Na+,K+-ATPase 
belongs to a P-type ATPase family and forms a 
phosphorylated intermediates (EP) in the catalytic 
cycle (32, 33). We studied if the association of 
KCC3a with α1NaK affects the phosphorylation 
level of Na+,K+-ATPase. In Fig.7A, membrane 
fractions of the tet-on cells were phosphorylated 
with [γ-32P] ATP under the different cationic 
conditions. The phosphorylated 100-kDa band 
was detected in the presence of 20 mM NaCl, and 
this band was diminished by the addition of 20 
mM KCl. No phosphorylated band was observed 
in the presence of 20 mM KCl or 20 mM 
choline-Cl instead of 20 mM NaCl (Fig. 7A). 
Phosphorylated level of the 100-kDa band was 
elevated by increasing the NaCl concentration, the 
maximal phosphorylation being observed at 100 
mM (Fig. 7B). Figure 7C shows that 
phosphorylation level of the 100-kDa band in the 
tet-on cells which express KCC3a is significantly 
greater than that in the tet-off cells which do not 
express KCC3a. These results suggest that the 
phosphorylation level of α1NaK is affected by the 
expression of KCC3a. 
Effects of DIOA, an inhibitor of KCC, on 
Na+,K+-ATPase activity. DIOA is known as a 
potent inhibitor of KCCs (IC50 = 10 µM) (34). 
Although high concentrations of DIOA (> 30 µM) 
suppressed Na+,K+-ATPase activity (IC50 = 53-95 
µM), no inhibitory effect of this drug on 
Na+,K+-ATPase was observed at a lower 
concentration of 10 µM (19). Here, DIOA (10 
µM) significantly inhibited the Na+,K+-ATPase 
activity of rabbit gastric glands (Fig. 8A) in which 
KCC3a is expressed (Fig. 1B), while it had no 
significant effect on the Na+,K+-ATPase activity 
of rabbit kidney (Fig. 8B) in which KCC3b but 
not KCC3a is expressed (Fig. 1C). These results 
suggest that Na+,K+-ATPase activity is positively 
regulated by KCC3a in the gastric parietal cells. 
Furthermore, DIOA (10 µM) inhibited the 
KCC3a-increased Na+,K+-ATPase activity in the 
tet-on cells, while it had no significant effects on 
the Na+,K+-ATPase activity in the tet-off cells 
(Fig. 8C). 
 
Ouabain-sensitive 22Na+ transport activity. To 
estimate Na+ transport activity of Na+,K+-ATPase 
in the tet-on and tet-off cells, the ouabain-sensitive 
change in the intracellular 22Na+ level was 
measured. Ouabain-sensitive 22Na+ transport 
activity in the tet-on cells was significantly greater 
than that in the tet-off cells (Fig. 9). DIOA (10 
µM) inhibited the KCC3a-increased Na+ transport 
activity in the tet-on cells, while it had no 
significant effects on the Na+ transport activity in 
the tet-off cells (Fig. 9). 
Effect of KCC4 on Na+,K+-ATPase. Finally, 
we studied effects of the expression of KCC4, 
which has 66% of amino acid identity compared 
with KCC3a (2, 3), on the raft distribution of 
α1NaK and the Na+,K+-ATPase activity. For this 
purpose, the tetracycline-regulated expression 
system of KCC4 was constructed in LLC-PK1 
cells. No significant expression of endogenous 
KCC4 was observed in control LLC-PK1 cells 
(data not shown). KCC4 expression (165 kDa) 
was observed in the cells treated with tetracycline 
(tet-on cells), while no significant KCC4 
expression was observed in the cells treated 
without tetracycline (tet-off cells) (Fig. 10A). In 
the tet-off cells, 35.8 ± 1.5% of total α1NaK was 
localized in the DRM fractions (Fig. 10, B and D). 
In the tet-on cells, KCC4 was highly distributed in 
the DRM fraction as well as the case for KCC3a 
(Fig. 10C), and 29.8 ± 4.3% of total α1NaK was 
localized in the DRM fractions (Fig. 10, C and D). 
These findings indicate that the presence and 
absence of KCC4 did not significantly affect the 
distribution of α1NaK between the DRM and 
non-DRM fractions (Fig. 10D). Furthermore, both 
the total expression level and the activity of 
Na+,K+-ATPase in the tet-on cells were not 
significantly different from those in the tet-off 
cells (Fig. 10, E and F), respectively. These results 
suggest that KCC4 is not functionally coupled to 
α1NaK. 




In the present study, we have found following 
facts. 1) KCC3a, a longest form of KCC3, is 
expressed in the basolateral membrane of gastric 
parietal cells. Interestingly KCC3a is expressed in 
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the luminal region of the glands and absent in the 
basal region of the glands. 2) KCC3a is associated 
with Na+,K+-ATPase α1-subunit (α1NaK) and 
both of them are highly localized in lipid rafts. 3) 
The ouabain-sensitive Na+,K+-ATPase activity in 
rabbit gastric mucosa is significantly inhibited by 
a KCC inhibitor (10 µM DIOA). 4) In LLC-PK1 
cells, the exogenous expression of KCC3a recruits 
α1NaK into lipid rafts, accompanying increases of 
Na+,K+-ATPase activity and ouabain-sensitive Na+ 
transport activity which are suppressed by DIOA. 
Furthermore, the expression of KCC3a affects the 
phosphorylation level of Na+,K+-ATPase. But, the 
expression of KCC4 does not recruit α1NaK into 
lipid rafts. 5) In HEK293 cells stably expressing 
exogenous H+,K+-ATPase, H+,K+-ATPase activity 
was not affected by additional expression of 
KCC3a. 
It has been suggested that the luminal parietal 
cells more actively secrete acid than do the basal 
parietal cells, because the luminal parietal cells 
have more transcriptional synthesizing activities 
for H+,K+-ATPase compared with the basal 
parietal cells (27, 28). For example, the luminal 
and basal parietal cells were assumed to secrete 
acid with pH of about 1 and 3, respectively, for 
the calculation of acid-activated quantity of gastric 
proton pump inhibitors (29). Furthermore, the 
secretory surface of luminal parietal cells was 
found to be greater than that of the basal parietal 
cells (35). Anion exchanger 2 (AE2), a Cl-/HCO3- 
exchanger, was reported to be highly expressed in 
the basolateral membrane of luminal parietal cells 
(6) as found here for KCC3a. AE2 is essential for 
gastric acid secretion in the parietal cells of rabbits 
(36) and mice (37) and for normal development of 
secretory canalicular and tubulovesicular 
membranes of mouse parietal cells (37). We have 
found that the role of KCC3a in the luminal 
parietal cells resides in recruitment of α1NaK into 
the lipid rafts. 
In contrast, NKCC1 and aquaporin-4 (AQP4) 
have been reported to be predominantly localized 
in the basolateral membrane of basal parietal cells 
(6, 26). In the mice lacking NKCC1 (7) or AQP4 
(38), gastric acid secretion was found to be 
normal. Thus, downward migration of gastric 
parietal cells from the generating region to the 
basal region of the gland is associated with 
expression of NKCC1 and AQP4 along with 
diminution of KCC3a and AE2, reflecting a 
process that is necessary for establishing different 
cell functions along the gastric glands. Previously, 
the parietal cells were proposed to undergo a 
programmed conversion of their principal function 
from acidic chloride (HCl) secretion to non-acidic 
chloride (NaCl or KCl) secretion on their 
migration (6, 8).  
Furthermore, we have found that association 
of KCC3a with α1NaK in lipid rafts of LLC-PK1 
cells increases Na+,K+-ATPase activity, the 
increment of which was inhibited by DIOA. These 
findings are interesting from the point of view that 
the ion transport by the secondary active 
transporter (KCC3a) up-regulates the primary 
active pump activity (α1NaK). There is another 
example that shows a functional coupling between 
KCC and Na+,K+-ATPase: in mouse brain, 
Na+,K+-ATPase α2-subunit and neuron-specific 
KCC2 were reported to be co-immunoprecipitated 
in purified synaptic membrane and functionally 
coupled to exclude Cl- from the cytosol in 
respiratory center neurons (39). 
Recently, other examples have been reported 
that Na+,K+-ATPase plays different roles 
depending on locations in membrane such as 
between caveolae and non-caveolae and between 
different types of lipid rafts. In LLC-PK1 cells, 
pumping and non-pumping Na+,K+-ATPase are 
present. The non-pumping Na+,K+-ATPase is 
associated with Src and/or extracellular 
signal-regulated kinase and present in caveolae of 
the cells (24, 40). Once ouabain binds to the 
non-pumping Na+,K+-ATPase, Src is activated and 
subsequent tyrosine phosphorylation of multiple 
effectors occurs (40). The pumping 
Na+,K+-ATPase is present in non-caveolae 
domains (24, 40). Over half of Na+,K+-ATPase is 
estimated to be non-pumping Na+,K+-ATPase 
(24). Depletion of cholesterol with MβCD in the 
cells increases the activity of Na+,K+-ATPase 
because of the conversion of the non-pumping 
pump into the pumping pump (41). In rainbow 
trout gill epithelium, Na+,K+-ATPase in the lipid 
raft enriched in sulfogalactosylceramide 
(SGC-enriched raft) acts as a normal pump, while 
the non-SGC/raft-associated Na+,K+-ATPase acts 
as a Na+-pump (12). These findings suggest that 
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caveolae and lipid rafts are the microdomains that 
give multiple functions to Na+,K+-ATPase in the 
basolateral membrane. 
In conclusion, we have found that KCC3a is 
abundantly expressed in the basolateral membrane 
of gastric luminal parietal cells and up-regulates 
the α1NaK activity in lipid rafts. The 
disappearance of KCC3a in the basal parietal cells 
may indicate that KCC3a is involved in the 
morphological and functional transitions of gastric 
parietal cells, which occur when the cells migrate 
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FIGURE 1.  Expression of KCC3a in gastric parietal cells.  A, Northern blotting was performed 
with poly A+ RNA (2.5 µg/lane) from isolated rabbit gastric parietal cells. A 8 kb-band was predominantly 
detected with the KCC3 cDNA probe. B, Western blotting was performed with gastric glands of rabbits 
(15 µg of protein) and gastric mucosa of rats (50 µg of protein) and humans (100 µg of protein) by using 
anti-KCC3 antibody. A single band of 180 kDa was observed (upper panel). The 180-kDa band was 
disappeared in the presence of the corresponding blocking peptide (lower panel). C, Western blotting was 
performed with gastric mucosa (50 µg of protein) and kidney of rats (100 µg of protein) by using 
anti-KCC3 antibody. The 180-kDa and 150-kDa bands were observed in gastric mucosa and kidney, 
respectively. 
 
FIGURE 2. Immunostaining for KCC3a in isolated rat gastric mucosa. (A-C) show the same tissue 
under a microscope. Similarly, (D-F), (G-I) and (J-L). Double immunostaining was performed with 
isolated rat gastric mucosa by using anti-KCC3 plus anti-H+,K+-ATPase antibodies (A-I), anti-KCC3 plus 
anti-Na+,K+-ATPase antibodies (J-L), anti-KCC3 plus anti-AQP4 antibodies (M) and anti-H+,K+-ATPase 
plus anti-AQP4 antibodies (N). A-F, localizations of KCC3a (A and D), H+,K+-ATPase (B and E), and 
KCC3a plus H+,K+-ATPase (merged image; C and F) are shown. G-I, anti-KCC3 antibody was pre-treated 
with the blocking peptide. Localizations of KCC3a (G), H+,K+-ATPase (H), and KCC3a plus 
H+,K+-ATPase (merged image; I). Positive KCC3a staining was disappeared (G). J-L, localizations of 
KCC3a (J), Na+,K+-ATPase (K), and KCC3a plus Na+,K+-ATPase (merged image; L). M, localizations of 
KCC3a (green color) plus AQP4 (red color). N, localizations of H+,K+-ATPase (green color) plus AQP4 
(red color). Original magnification: x 20 (A-C, M and N) and x 40 (D-L). Scale bars, 10 µm.   
 
FIGURE 3. Association of KCC3a and α1NaK in rat gastric mucosa.  A, immunoprecipitation (IP) 
was performed with the detergent extracts of rat gastric mucosa by using anti-KCC3 antibody and protein 
A agarose. The detergent extracts (input; 1/25 (for KCC3) or 1/200 (for α1NaK and αHK) of total protein) 
and IP samples obtained with and without the antibody (1/20 of IP samples) were detected by Western 
blotting (WB) using antibodies for KCC3 (upper panel), Na+,K+-ATPase α1-subunit (α1NaK; middle 
panel) and H+,K+-ATPase α-subunit (αHK; bottom panel).  B, lipid raft fractions (DRM) and non-raft 
fractions (non-DRM) were isolated from membrane fractions of rat gastric mucosa by sucrose gradient 
(5-40%) as described in Experimental Procedures. Western blotting was performed by using antibodies 
for KCC3, α1NaK and flotillin-2. 
 
FIGURE 4. Tetracycline-regulated expression system of KCC3a in LLC-PK1 cells. The 
tetracycline-regulated expression system of KCC3a was introduced to LLC-PK1 cells. The cells were 
treated with (Tet-on) or without (Tet-off) 2 µg/ml tetracycline. The expression of KCC3a was confirmed 
by Western blotting (A) and immunocytochemistry (B and C) using anti-Xpress antibody. In the cells, 
α1NaK was localized in the basolateral membrane (D, E and G). In the tet-on cells, KCC3a was localized 
in the basolateral membrane (F). Scale bars, 10 µm. 
 
FIGURE 5.  Lipid raft analysis of the tetracycline-regulated expression system of KCC3a. A and 
B, lipid raft fractions (DRM) and non-raft fractions (non-DRM) were isolated from membrane fractions of 
the LLC-PK1 cells (A, tet-off cells, B, tet-on cells) by sucrose gradient (5-40%) as described in 
Experimental Procedures. Western blotting was performed by using antibodies for KCC3a (anti-Xpress 
antibody), α1NaK and flotillin-2. C, expression level of α1NaK in the DRM and non-DRM fractions in the 
tet-on and tet-off cells. Intensity of the 100-kDa band of α1NaK was measured by densitometry, and 
percentages of α1NaK in the DRM and non-DRM fractions relative to total amount of α1NaK in the 
membrane fractions were calculated. n = 3.  **, significantly different (p < 0.01). D, the membrane 
fractions of the tet-on cells were treated with 10 mM MβCD for 30 min at 37°C. 
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FIGURE 6. Up-regulation of the α1NaK activity by KCC3a.  A, immunoprecipitation (IP) was 
performed with the detergent extracts of the KCC3a-expressing cells (tet-on cells) by using anti-KCC3 
antibody and protein A agarose. As control experiments, control rabbit IgG instead of the antibody was 
used. The detergent extracts (input; 1/75 (for KCC3a) or 1/150 (for α1NaK) of total protein) and IP 
samples obtained with the IgG ((-); 1/22 of the IP sample) and with the anti-KCC3 antibody (KCC3; 1/22 
of the IP sample) were detected by Western blotting using anti-Xpress antibody (detecting for KCC3a; left 
panel) and anti-α1NaK antibody (right panel). B, the total expression level of α1NaK in the tet-on cells 
was compared with that in the tet-off cells. In the upper panel, a representative picture of Western blotting 
is shown. The score for tet-off cells is normalized as 1. n = 8. NS, not significantly different (p > 0.05). C, 
Na+,K+-ATPase activity in the tet-on and tet-off cells. The score for tet-off cells is normalized as 1. n = 8. 
**, significantly different (p < 0.01). 
 
FIGURE 7. Increase in the phosphorylation level of Na+,K+-ATPase by KCC3a. A, a membrane 
fraction of the tet-on cells was incubated with [γ-32P] ATP in the presence of 20 mM NaCl (NaCl), 20 mM 
NaCl plus 20 mM KCl (NaCl+KCl), 20 mM KCl (KCl), or 20 mM choline chloride (CholineCl).  
Radioactive 100-kDa band was observed only in the presence of 20 mM NaCl. B, increases in the intensity 
of radioactive 100-kDa band by increasing the NaCl concentration. The level of phosphorylated 
intermediates (EP) in the presence of 100 mM NaCl is normalized as 100%. n = 3. In the upper panel, a 
representative picture is shown. C, EP levels of Na+,K+-ATPase in the tet-on and tet-off cells. The EP 
level was measured in the presence of 20 mM NaCl. The score for tet-off cells is normalized as 1. n = 8. 
**, significantly different (p < 0.01). In the upper panels, representative pictures of the phosphorylated 
α1NaK (EP) and Western blotting for α1NaK (WB) are shown. 
 
FIGURE 8. Effects of DIOA, an inhibitor of KCC, on Na+,K+-ATPase activity. A and B, 
Na+,K+-ATPase activity in the membrane fractions of gastric glands (A) and kidney (B) of rabbits were 
measured in the absence and presence of 10 µM DIOA. n = 4. **, significantly different (p < 0.01). NS, 
not significantly different (p > 0.05). C, Na+,K+-ATPase activity in the absence and presence of 10 µM 
DIOA were measured in the membrane fractions of the KCC3a-expressing cells (Tet-on) and the KCC3a 
non-expressing cells (Tet-off). n = 6. **, p < 0.01; NS, not significant (p > 0.05). 
 
FIGURE 9. Up-regulation of the ouabain-sensitive 22Na+ transport activity by KCC3a and 
inhibition of the KCC3a-increased transport activity by DIOA. Ouabain-sensitive 22Na+ transport 
activity in the absence and presence of 10 µM DIOA were measured in the KCC3a-expressing cells 
(Tet-on) and the KCC3a non-expressing cells (Tet-off). The ouabain-sensitive Na+ transport activity in the 
tet-off cells in the absence of DIOA was calculated to be 4.92 ± 0.05 nmol/105 cells/min (n = 5). The score 
for tet-off cells in the absence of DIOA is normalized as 1 (open bar). n = 5. *, p < 0.05; **, p < 0.01; NS, 
not significant (p > 0.05). 
 
FIGURE 10. No association of KCC4 with α1NaK. The tetracycline-regulated expression system of 
KCC4 was introduced into LLC-PK1 cells. The cells were treated with (Tet-on) or without (Tet-off) 2 
µg/ml tetracycline. A, the expression of KCC4 was confirmed by Western blotting using anti-Xpress 
antibody. B and C, lipid raft fractions (DRM) and non-raft fractions (non-DRM) were isolated from 
membrane fractions of the KCC4 non-expressing cells (Tet-off; B) and the KCC4-expressing cells 
(Tet-on; C) by sucrose gradient (5-40%). Western blotting was performed by using antibodies for KCC4 
(anti-Xpress antibody), α1NaK and flotillin-2. D, expression level of α1NaK in the DRM and non-DRM 
fractions in the tet-on and tet-off cells. Intensity of the 100-kDa band of α1NaK (B and C) was measured 
by densitometry, and percentages of α1NaK in the DRM and non-DRM fractions relative to total amount 
of α1NaK in the membrane fractions were calculated. n = 3. NS, not significant (p > 0.05). E, the total 
expression level of α1NaK in the tet-on cells was compared with that in the tet-off cells. In the upper 
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panel, a representative picture of Western blotting is shown. The score for tet-off cells is normalized as 1. 
n = 6. NS, not significant (p > 0.05). F, Na+,K+-ATPase activity in the tet-on and tet-off cells. The score 
for tet-off cells is normalized as 1. n = 6. NS, not significant (p > 0.05). 
 
 
Supplemental FIGURE 1. No association of KCC3a with H+,K+-ATPase. A, the expression level of 
H+,K+-ATPase α-subunit (αHK) in the KCC3a-transfected HEK293 cells (KCC3a) and pcDNA4/His 
vector-transfected HEK293 cells (mock). The score for mock cells is normalized as 1. n = 8. NS, not 
significant (p > 0.05). In the upper panel, a representative picture of Western blotting for H+,K+-ATPase is 
shown. B, H+,K+-ATPase activity in the KCC3a-transfected cells was compared with that in the mock 
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